Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging

作者：Luigi P. Badano, Theodore J. Kolias, Denisa Muraru, Theodore P. Abraham, Gerard P. Aurigemma, Thor Edvardsen, Jan D’hooge, Erwan Donal, Alan G. Fraser, Thomas H. Marwick, Luc Mertens, Bogdan A. Popescu, Partho P. Sengupta, Patrizio Lancellotti, James D. Thomas, Jens‐Uwe Voigt, Industry representatives, David Prater, Tomoaki Chono, Bernhard Mumm, Hélène Houle, Siemens Healthineers, Gunnar Hansen, Yasuhiko Abe, Stefano Pedri, Victoria Delgado, Alessia Gimelli, Bernard Cosyns, Bernhard Gerber, Frank A. Flachskampf, Kristina H. Haugaa, Maurizio Galderisi, Nuno Cardim, Philipp A. Kaufmann, Pier Giorgio Masci, Nina Ajmone Marsan, Monica Roşca, Matteo Cameli, Leyla Elif Sade · 发表于：European Heart Journal - Cardiovascular Imaging · 年份：2018 · DOI：10.1093/ehjci/jey042 · 被引用次数：1701 · 研究领域：Cardiovascular Function and Risk Factors、Cardiac Imaging and Diagnostics、Cardiac Valve Diseases and Treatments

The EACVI/ASE/Industry Task Force to standardize deformation imaging prepared this consensus document to standardize definitions and techniques for using two-dimensional (2D) speckle tracking echocardiography (STE) to assess left atrial, right ventricular, and right atrial myocardial deformation. This document is intended for both the technical engineering community and the clinical community at large to provide guidance on selecting the functional parameters to measure and how to measure them using 2D STE.This document aims to represent a significant step forward in the collaboration between the scientific societies and the industry since technical specifications of the software packages designed to post-process echocardiographic datasets have been agreed and shared before their actual development. Hopefully, this will lead to more clinically oriented software packages which will be better tailored to clinical needs and will allow industry to save time and resources in their development.